Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
1.660
-0.100 (-5.68%)
May 16, 2025, 10:06 AM - Market open
IOVA's stock price has decreased by -84.32% in the past year and price targets may not have had time to catch up.
Iovance Biotherapeutics Analyst Ratings
Total Analysts
10
Consensus Rating
Buy
Price Target
$12.22
Upside
+636.14%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy → Hold Downgrades $17 → $2 | Strong Buy → Hold | Downgrades | $17 → $2 | +20.48% | May 16, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $16 → $8 | Strong Buy | Maintains | $16 → $8 | +381.93% | May 12, 2025 |
| Mizuho | Mizuho | Buy Maintains $30 → $10 | Buy | Maintains | $30 → $10 | +502.41% | May 12, 2025 |
| Barclays | Barclays | Buy Maintains $5 → $4 | Buy | Maintains | $5 → $4 | +140.96% | May 12, 2025 |
| JMP Securities | JMP Securities | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | May 9, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $30 → $25 | Strong Buy | Maintains | $30 → $25 | +1,406.02% | May 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $32 → $20 | Strong Buy | Maintains | $32 → $20 | +1,104.82% | May 9, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $18 → $16 | Strong Buy | Maintains | $18 → $16 | +863.86% | Apr 17, 2025 |
| Barclays | Barclays | Buy Maintains $22 → $5 | Buy | Maintains | $22 → $5 | +201.20% | Apr 14, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $25 → $15 | Strong Buy | Maintains | $25 → $15 | +803.61% | Mar 3, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $22 → $19 | Strong Buy | Maintains | $22 → $19 | +1,044.58% | Mar 3, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $34 → $30 | Strong Buy | Maintains | $34 → $30 | +1,707.23% | Mar 3, 2025 |
| Baird | Baird | Buy Maintains $24 → $20 | Buy | Maintains | $24 → $20 | +1,104.82% | Feb 28, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $7.5 → $6 | Hold | Maintains | $7.5 → $6 | +261.45% | Feb 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +1,827.71% | Feb 28, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $10 → $7.5 | Hold | Maintains | $10 → $7.5 | +351.81% | Jan 31, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.